Skip to main content
Premium Trial:

Request an Annual Quote

Still Available

After more than a year in office, US President Donald Trump has yet to appoint a science advisor, the Huffington Post reports. It notes that that's the longest the position, which oversees the White House Office of Science and Technology Policy, has been vacant since 1976.

"It's vital for the president to get the best science advice, and right now, he isn't getting that. His decisions are being made without the benefit of science," John Holdren, who served as science advisor during the Obama Administration, tells the Boston Globe.

But, the Huffington Post adds, that that might not be for a lack of trying. Science reported last week that White House logs indicate that three candidates for the position were interviewed last spring. It's not clear, Science said, whether the job was offered to any of the candidates — their names were redacted from the log for privacy — but it said the interviews indicate that the Trump Administration has attempted to fill the position.

In a January op-ed in the New York Times, Rice University's Neal Lane, a former science advisor during the Clinton Administration, and Stanford University's Michael Riordan said that it might be difficult to find a scientist willing to serve in that capacity because of President Trump's "obvious disdain for science." However, an admittedly unscientific survey by Science in December found that about half the scientists they asked said they'd at least consider taking the role. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.